{"entity":{"type":"insider","cik":"0001825445","url":"/insider/0001825445","json_url":"/insider/0001825445.json","name":"Crystal Adam","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":30,"n_filings":18,"first":"2021-04-06","last":"2026-08-05","span_basis":"filed_date"},"name_variants":[{"name":"Crystal Adam","source":"filing","n_filings":18,"first_seen":"2021-04-06","last_seen":"2026-08-05"}],"transactions":[{"id":5837930,"accession":"0001193125-26-335002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-335002","line_url":"/filing/0001193125-26-335002","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":27.241385414814815,"price_display":"27.24","price_state":"stated","total_value":735517.4062,"total_display":"735,517.41","total_whole":"735,517","shares_owned_after":115743.0,"shares_owned_after_display":"115,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-05","scope":"insider","n_lines":2},{"id":6235567,"accession":"0001193125-26-295124","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-295124","line_url":"/filing/0001193125-26-295124","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":29.589192,"price_display":"29.59","price_state":"stated","total_value":798908.184,"total_display":"798,908.18","total_whole":"798,908","shares_owned_after":123114.0,"shares_owned_after_display":"123,114","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider","n_lines":2},{"id":5810270,"accession":"0001193125-26-255940","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-255940","line_url":"/filing/0001193125-26-255940","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":22.873009925925928,"price_display":"22.87","price_state":"stated","total_value":617571.268,"total_display":"617,571.27","total_whole":"617,571","shares_owned_after":115743.0,"shares_owned_after_display":"115,743","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-03","scope":"insider","n_lines":2},{"id":6062533,"accession":"0001193125-26-207096","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-207096","line_url":"/filing/0001193125-26-207096","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":21.225827037037035,"price_display":"21.23","price_state":"stated","total_value":573097.33,"total_display":"573,097.33","total_whole":"573,097","shares_owned_after":116843.0,"shares_owned_after_display":"116,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-05","scope":"insider","n_lines":2},{"id":6073254,"accession":"0001193125-26-159747","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-159747","line_url":"/filing/0001193125-26-159747#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":38460.0,"shares_display":"38,460","price_per_share":25.0,"price_display":"25.00","price_state":"stated","total_value":961500.0,"total_display":"961,500.00","total_whole":"961,500","shares_owned_after":112622.0,"shares_owned_after_display":"112,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-15","filed_date":"2026-04-16","scope":"insider"},{"id":6172461,"accession":"0001193125-26-140874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-140874","line_url":"/filing/0001193125-26-140874#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27000.0,"shares_display":"27,000","price_per_share":21.2029,"price_display":"21.20","price_state":"stated","total_value":572478.3,"total_display":"572,478.30","total_whole":"572,478","shares_owned_after":112622.0,"shares_owned_after_display":"112,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-02","scope":"insider"},{"id":5894191,"accession":"0001193125-26-129990","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001193125-26-129990","line_url":"/filing/0001193125-26-129990#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12000.0,"shares_display":"12,000","price_per_share":20.11,"price_display":"20.11","price_state":"stated","total_value":241320.0,"total_display":"241,320.00","total_whole":"241,320","shares_owned_after":112622.0,"shares_owned_after_display":"112,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-25","filed_date":"2026-03-27","scope":"insider"},{"id":6195119,"accession":"0001193125-26-098443","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-098443","line_url":"/filing/0001193125-26-098443#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":20251.0,"shares_display":"20,251","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":303765.0,"total_display":"303,765.00","total_whole":"303,765","shares_owned_after":112622.0,"shares_owned_after_display":"112,622","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-05","filed_date":"2026-03-09","scope":"insider"},{"id":5822498,"accession":"0001193125-26-083579","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193125-26-083579","line_url":"/filing/0001193125-26-083579#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":54345.0,"shares_display":"54,345","price_per_share":12.7741,"price_display":"12.77","price_state":"stated","total_value":694208.4645,"total_display":"694,208.46","total_whole":"694,208","shares_owned_after":132873.0,"shares_owned_after_display":"132,873","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-25","filed_date":"2026-02-27","scope":"insider"},{"id":5943334,"accession":"0001193125-26-038052","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001193125-26-038052","line_url":"/filing/0001193125-26-038052","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (President, R&D)","role_mark":"O","role_mark_label":"Officer (President, R&D)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President, R&D","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18452.0,"shares_display":"18,452","price_per_share":12.26426942336874,"price_display":"12.26","price_state":"stated","total_value":226300.2994,"total_display":"226,300.30","total_whole":"226,300","shares_owned_after":187419.0,"shares_owned_after_display":"187,419","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-03","filed_date":"2026-02-04","scope":"insider","n_lines":2},{"id":4494537,"accession":"0000950170-25-015693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-015693","line_url":"/filing/0000950170-25-015693#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6851.0,"shares_display":"6,851","price_per_share":3.1614,"price_display":"3.16","price_state":"stated","total_value":21658.7514,"total_display":"21,658.75","total_whole":"21,659","shares_owned_after":158210.0,"shares_owned_after_display":"158,210","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-05","filed_date":"2025-02-06","scope":"insider"},{"id":4494535,"accession":"0000950170-25-015693","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-015693","line_url":"/filing/0000950170-25-015693#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7432.0,"shares_display":"7,432","price_per_share":2.988,"price_display":"2.99","price_state":"stated","total_value":22206.816,"total_display":"22,206.82","total_whole":"22,207","shares_owned_after":165061.0,"shares_owned_after_display":"165,061","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-04","filed_date":"2025-02-06","scope":"insider"},{"id":2733994,"accession":"0000950170-24-012991","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-24-012991","line_url":"/filing/0000950170-24-012991#line-2","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4083.0,"shares_display":"4,083","price_per_share":12.6198,"price_display":"12.62","price_state":"stated","total_value":51526.6434,"total_display":"51,526.64","total_whole":"51,527","shares_owned_after":119478.0,"shares_owned_after_display":"119,478","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-07","filed_date":"2024-02-08","scope":"insider"},{"id":2733990,"accession":"0000950170-24-012991","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-012991","line_url":"/filing/0000950170-24-012991#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4288.0,"shares_display":"4,288","price_per_share":12.5626,"price_display":"12.56","price_state":"stated","total_value":53868.4288,"total_display":"53,868.43","total_whole":"53,868","shares_owned_after":123561.0,"shares_owned_after_display":"123,561","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-02-06","filed_date":"2024-02-08","scope":"insider"},{"id":8518625,"accession":"0000950170-23-058314","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-058314","line_url":"/filing/0000950170-23-058314#line-1","is_derivative":false,"issuer_cik":"0001819133","issuer_name":"Tango Therapeutics, Inc.","issuer_ticker":"TNGX","issuer_name_source":null,"issuer_url":"/issuer/0001819133","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7507.0,"shares_display":"7,507","price_per_share":8.3914,"price_display":"8.39","price_state":"stated","total_value":62994.2398,"total_display":"62,994.24","total_whole":"62,994","shares_owned_after":81250.0,"shares_owned_after_display":"81,250","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-01","filed_date":"2023-11-02","scope":"insider"},{"id":6692820,"accession":"0001209191-22-001700","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-001700","line_url":"/filing/0001209191-22-001700","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":31.664509666666667,"price_display":"31.66","price_state":"stated","total_value":474967.645,"total_display":"474,967.64","total_whole":"474,968","shares_owned_after":16054.0,"shares_owned_after_display":"16,054","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider","n_lines":2},{"id":4287342,"accession":"0001209191-21-059512","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-21-059512","line_url":"/filing/0001209191-21-059512","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.42922768,"price_display":"45.43","price_state":"stated","total_value":681438.4152,"total_display":"681,438.42","total_whole":"681,438","shares_owned_after":5112.0,"shares_owned_after_display":"5,112","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-01","filed_date":"2021-10-05","scope":"insider","n_lines":3},{"id":4485298,"accession":"0001209191-21-049114","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-049114","line_url":"/filing/0001209191-21-049114#line-2","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":45.0,"price_display":"45.00","price_state":"stated","total_value":675000.0,"total_display":"675,000.00","total_whole":"675,000","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-29","filed_date":"2021-08-02","scope":"insider"},{"id":5477266,"accession":"0001209191-21-045691","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-045691","line_url":"/filing/0001209191-21-045691","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":37.97771933333333,"price_display":"37.98","price_state":"stated","total_value":569665.79,"total_display":"569,665.79","total_whole":"569,666","shares_owned_after":1700.0,"shares_owned_after_display":"1,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-01","filed_date":"2021-07-06","scope":"insider","n_lines":2},{"id":5467900,"accession":"0001209191-21-025664","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-025664","line_url":"/filing/0001209191-21-025664","is_derivative":false,"issuer_cik":"0001662579","issuer_name":"C4 Therapeutics, Inc.","issuer_ticker":"CCCC","issuer_name_source":null,"issuer_url":"/issuer/0001662579","owner_cik":"0001825445","owner_name":"Crystal Adam","owner_display_name":"Crystal Adam","owner_url":"/insider/0001825445","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":37.76906464,"price_display":"37.77","price_state":"stated","total_value":566535.9696,"total_display":"566,535.97","total_whole":"566,536","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-05","filed_date":"2021-04-06","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":30,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":30,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":30},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001819133","name":"Tango Therapeutics, Inc.","url":"/issuer/0001819133","role":"Officer (President, R&D)","n_filings":13,"first_seen":"2023-11-02","last_seen":"2026-08-05"},{"type":"issuer","type_label":"ISSUER","cik":"0001662579","name":"C4 Therapeutics, Inc.","url":"/issuer/0001662579","role":"Officer (Chief Medical Officer)","n_filings":5,"first_seen":"2021-04-06","last_seen":"2022-01-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001825445","retrieved_at":"2026-08-24T02:11:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}